User profiles for "author:Philippos Apolinario Costa"
Philippos Apolinario CostaResident Verified email at jhsmiami.org Cited by 127 |
[HTML][HTML] Genomic landscape of angiosarcoma: a targeted and immunotherapy biomarker analysis
Simple Summary Angiosarcomas (AS) are rare, highly aggressive sarcomas with limited
therapeutic options. Genomic sequencing techniques have identified recurrent genetic …
therapeutic options. Genomic sequencing techniques have identified recurrent genetic …
[HTML][HTML] Giant bullous emphysema mistaken for traumatic pneumothorax
EGF Junior, PA Costa, LMFG Silveira… - International journal of …, 2019 - Elsevier
Introduction: Giant bullous emphysema (GBE) is defined by giant bullae in one or both upper
lobes, occupying at least one-third of the hemithorax and compressing the surrounding …
lobes, occupying at least one-third of the hemithorax and compressing the surrounding …
[HTML][HTML] Neoadjuvant Intra-arterial Cytoreductive Chemotherapy Improves Outcomes in Lacrimal Gland Adenoid Cystic Carcinoma
PA Costa, DT Tse, P Benedetto - The Oncologist, 2024 - academic.oup.com
Background Lacrimal gland adenoid cystic carcinoma (LGACC) has historically been
associated with a poor prognosis even with localized disease, with a survival of 56% at 5 …
associated with a poor prognosis even with localized disease, with a survival of 56% at 5 …
Panuveitis induced by brentuximab vedotin: a possible novel adverse event of an antibody-drug conjugate
PA Costa, AP Espejo-Freire, KC Fan… - Leukemia & …, 2022 - Taylor & Francis
Brentuximab vedotin (BV) is an antibody-drug conjugate composed of an anti-CD30
monoclonal antibody conjugated through a linker to the microtubule disturbing agent …
monoclonal antibody conjugated through a linker to the microtubule disturbing agent …
A nonrandom association of breast implants and the formation of desmoid tumors
PA Costa, S Marbin, BMLA Costa… - The breast …, 2021 - Wiley Online Library
Background Studies suggest that surgical breast augmentation with implants is a risk factor
for breast desmoid tumors. The statistical strength of this correlation is unknown, as …
for breast desmoid tumors. The statistical strength of this correlation is unknown, as …
Clinical attributes and outcomes in metastatic non-small cell lung cancer bearing BRAF mutations treated with targeted therapy versus immunotherapy.
e21219 Background: Mutations in BRAF oncogene have been identified in about 2-4% of
non-small cell lung cancer (NSCLC) patients. Combination of tyrosine kinase inhibitors …
non-small cell lung cancer (NSCLC) patients. Combination of tyrosine kinase inhibitors …
KIT resistance mutations identified by circulating tumor DNA and treatment outcomes in advanced gastrointestinal stromal tumor.
S Bialick, BE Rose, AP Espejo-Freire, P Barreto Coelho… - 2022 - ascopubs.org
11514 Background: Tyrosine kinase inhibitors (TKIs) are the cornerstone treatment for
advanced GIST via pharmacologic targeting of driver oncogenes such as KIT. Detection of …
advanced GIST via pharmacologic targeting of driver oncogenes such as KIT. Detection of …
[PDF][PDF] Clinical outcomes of cancer patients with COVID-19: A systematic review and meta-analysis
M Alasfour, S Alawadi, M AlMojel… - Journal of Clinical …, 2021 - posterpresentations.com
• Initial Comprehensive search yielded 2,618 studies. After excluding duplicates and those
that do not meet inclusion criteria, 34 studies were included in the final analysis. That brings …
that do not meet inclusion criteria, 34 studies were included in the final analysis. That brings …
[HTML][HTML] Dose escalation of ripretinib can lead to response in advanced gastrointestinal stromal tumor patients refractory to the standard dose: A report of two cases
Despite an initial response, most metastatic gastrointestinal stromal tumor (GIST) patients
will ultimately be refractory to all current therapies, including imatinib, sunitinib, and …
will ultimately be refractory to all current therapies, including imatinib, sunitinib, and …
[HTML][HTML] Transhiatal esophagectomy with gastric pull-up, pyloric exclusion and Roux-en-Y gastroenterostomy for the management of esophageal caustic injury
EGF Junior, PA Costa, LMFG Silveira… - International journal of …, 2019 - Elsevier
Introduction Ingestion of caustic materials can lead to digestive tube perforation involving the
mouth, pharynx, esophagus and stomach (Vezakis et al., 2016 [1]). In this case report, the …
mouth, pharynx, esophagus and stomach (Vezakis et al., 2016 [1]). In this case report, the …